Loading chat...
NY S02128
Bill
Status
2/24/2026
Primary Sponsor
Robert Jackson
Click for details
AI Summary
-
Requires health insurers to reduce enrollees' out-of-pocket costs (deductibles and coinsurance) for prescription drugs by at least 85% of all rebates received from manufacturers, pharmacies, or other parties at the point of sale
-
Defines "rebates" broadly to include base price concessions, price protection rebates triggered by wholesale cost increases, performance-based concessions, and administrative fees passed through to insurers
-
Mandates insurers submit annual certifications to the superintendent by January 1st attesting compliance with rebate pass-through requirements for the prior calendar year
-
Protects rebate information as confidential, exempting it from public disclosure requirements and prohibiting release of product-specific, manufacturer-specific, or pharmacy-specific rebate amounts
-
Applies to health insurers regulated under state law, including state and local governmental employer plans, with provisions added to both the Insurance Law and Public Health Law; effective for contracts issued, renewed, or amended on or after January 1, 2025
Legislative Description
Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.
Last Action
referred to insurance
2/24/2026